Ranolazine and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranolazine (ranolazine) and Keppra (levetiracetam). Common drug interactions include abdominal discomfort among females and malaise among males.

The phase IV clinical study analyzes what interactions people have when they take Ranolazine and Keppra. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Ranolazine?

Ranolazine has active ingredients of ranolazine. eHealthMe is studying from 9,939 Ranolazine users. Check the latest studies of Ranolazine.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

On Jul, 17, 2026

19 people who take Ranolazine and Keppra together, and have interactions are studied.

Ranolazine and Keppra drug interactions.

What are the common drug interactions of Ranolazine and Keppra, by gender? *:

female:

Abdominal discomfort
Diarrhoea
Memory impairment
Balance disorder
Headache (pain in head)
Myalgia (muscle pain)
Psychotic disorder
Suicidal ideation
Vision blurred
Femoral neck fracture (neck of femur bone fracture)

male:

Malaise (a feeling of general discomfort or uneasiness)
Arthralgia (joint pain)
Back pain
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Haematochezia (passage of stools containing blood)
Spinal cord injury lumbar (spinal cord injury at lumbar vertebrae region)
Vision blurred
Weight decreased
Abnormal behaviour

What are the common drug interactions of Ranolazine and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Arthralgia (joint pain)
Blood creatine phosphokinase increased
Malaise (a feeling of general discomfort or uneasiness)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Vomiting
Brain stem glioma (cancerous glioma tumour in the brainstem)
Decreased appetite
Diarrhoea

20-29:

n/a

30-39:

n/a

40-49:

Overdose

50-59:

n/a

60+:

Vision blurred
Back pain
Abnormal behaviour
Acute left ventricular failure (heart attack)
Acute myocardial infarction (acute heart attack)
Acute respiratory failure
Aggression
Anger
Balance disorder
Chronic kidney disease

What are the existing conditions these people have? *

Stable Angina (a constant chest pain): 5 people, 26.32%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 26.32%
High Blood Cholesterol: 3 people, 15.79%
Abdominal Discomfort: 2 people, 10.53%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 10.53%
Parkinson's Disease: 2 people, 10.53%
Pain: 2 people, 10.53%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%
Back Pain: 2 people, 10.53%
Brain Stem Glioma (cancerous glioma tumour in the brainstem): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ranolazine and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously